Superficial Radiation Therapy System Comprehensive Study by Type (External Beam Superficial Radiotherapy, Internal Superficial Radiotherapy), Application (Hospitals, Ambulatory Surgical Centers, Cancer Centers, Specialized Clinics), Disease Type (Dupuytren’s Contracture, Heterotopic Ossification, Ledderhose Disease, Peyronie’s Disease, Psoriasis, Viral Warts, Keloids), Treatment Type (Curative Treatment, Palliative Treatment) Players and Region - Global Market Outlook to 2026

Superficial Radiation Therapy System Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Superficial Radiation Therapy System Market?

Superficial radiation therapy systems are used to treat tumors and reduce pain, pressure, and other cancer symptoms. This therapy is used to cure a number of different types of cancer, but particularly non-melanoma forms of skin cancer. Superficial radiation therapy is low-level radiation therapy that penetrates under the surface of the skin. Superficial radiation therapies are extremely painless, effective and a cosmetic alternative to surgery for selected types of cancer. The superficial radiation therapy system emits radiation that disrupts cell division by targeting abnormal cells. The tumor cells divide faster than normal cells, making the tumor cells an easy target for radiation. Most radiation therapies are deeply penetrating and can reach tissues deep in the body and destroy cancer cells. However, the superficial radiation therapy system sends out a low-energy radiation therapy that only penetrates the outer layers of tissue and skin. Superficial radiation therapy systems are used to treat early-stage skin cancer and benign (non-cancerous) conditions. Some of the benign conditions treated by superficial radiation therapy systems are Dupuytren's contracture, heterotopic ossification, Ledderhose disease, Peyronie's disease, psoriasis, viral warts, keloids, etc. Skin cancer treated with superficial radiation therapy systems are basal cell carcinoma (BCC), Squamous cell carcinoma (SCC), and lentigo maligna. Basal cell carcinoma and squamous cell carcinoma are collectively known as non-melanoma skin cancer (NMSC).

The market study is being classified by Type (External Beam Superficial Radiotherapy and Internal Superficial Radiotherapy), by Application (Hospitals, Ambulatory Surgical Centers, Cancer Centers and Specialized Clinics) and major geographies with country level break-up.

Sensus Healthcare, Inc. (United States), OraSure Technologies Inc. (United States), Xstrahl Limited (United Kingdom), Nephros (United States), Nordion Inc. (Canada), RaySearch Laboratories AB (Sweden), Ion Beam Applications SA (Belgium), Mevion Medical Systems Inc. (United States), Varian Medical Systems Inc. (United States), IsoRay Medical Inc. (United States), Elekta AB (Sweden) and Mitsubishi Electric Corporation (Japan) are some of the key players profiled in the study.

The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Superficial Radiation Therapy System market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Superficial Radiation Therapy System market by Type, Application and Region.

On the basis of geography, the market of Superficial Radiation Therapy System has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • The Rising Incidence of Various Types of Cancers
  • The Safety and Effectiveness of Superficial Radiation Therapy Systems in Treating Malignant Non-Melanoma Skin Cancer

Market Trend
  • The Demand for Superficial Radiation Therapy System for Treating Non-Melanoma Cancer
  • Fast Varying Cancer Treatment Technologies

Restraints
  • High Costs Associated With the Use of Superficial Radiation Therapy Systems

Opportunities
  • The Improvement of Cancer Treatment and Inclination towards the Non-Invasive Procedures of Treatment

Challenges
  • The Absence of Qualified Workers for the Appropriate Use of Superficial Radiation Therapy System


Sensus Healthcare is a key provider of cutting-edge technologies and devices for improved testing, treatment, and diagnosis. The use of the SRT-100™ system developed by Sensus helps in the safe and resilient discharge of radiation. Furthermore, the system helps in precise and accurate penetration of radiation, up to 5 mm underneath the skin surface.


Key Target Audience
Providers of Superficial Radiation Therapy System, End-Users, Potential Investors, Regulatory Bodies, Market Research Firms and Others

Report Objectives / Segmentation Covered

By Type
  • External Beam Superficial Radiotherapy
  • Internal Superficial Radiotherapy
By Application
  • Hospitals
  • Ambulatory Surgical Centers
  • Cancer Centers
  • Specialized Clinics
By Disease Type
  • Dupuytren’s Contracture
  • Heterotopic Ossification
  • Ledderhose Disease
  • Peyronie’s Disease
  • Psoriasis
  • Viral Warts
  • Keloids

By Treatment Type
  • Curative Treatment
  • Palliative Treatment

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Rising Incidence of Various Types of Cancers
      • 3.2.2. The Safety and Effectiveness of Superficial Radiation Therapy Systems in Treating Malignant Non-Melanoma Skin Cancer
    • 3.3. Market Challenges
      • 3.3.1. The Absence of Qualified Workers for the Appropriate Use of Superficial Radiation Therapy System
    • 3.4. Market Trends
      • 3.4.1. The Demand for Superficial Radiation Therapy System for Treating Non-Melanoma Cancer
      • 3.4.2. Fast Varying Cancer Treatment Technologies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Superficial Radiation Therapy System, by Type, Application, Disease Type, Treatment Type and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Superficial Radiation Therapy System (Value)
      • 5.2.1. Global Superficial Radiation Therapy System by: Type (Value)
        • 5.2.1.1. External Beam Superficial Radiotherapy
        • 5.2.1.2. Internal Superficial Radiotherapy
      • 5.2.2. Global Superficial Radiation Therapy System by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Ambulatory Surgical Centers
        • 5.2.2.3. Cancer Centers
        • 5.2.2.4. Specialized Clinics
      • 5.2.3. Global Superficial Radiation Therapy System by: Disease Type (Value)
        • 5.2.3.1. Dupuytren’s Contracture
        • 5.2.3.2. Heterotopic Ossification
        • 5.2.3.3. Ledderhose Disease
        • 5.2.3.4. Peyronie’s Disease
        • 5.2.3.5. Psoriasis
        • 5.2.3.6. Viral Warts
        • 5.2.3.7. Keloids
      • 5.2.4. Global Superficial Radiation Therapy System by: Treatment Type (Value)
        • 5.2.4.1. Curative Treatment
        • 5.2.4.2. Palliative Treatment
      • 5.2.5. Global Superficial Radiation Therapy System Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Superficial Radiation Therapy System (Volume)
      • 5.3.1. Global Superficial Radiation Therapy System by: Type (Volume)
        • 5.3.1.1. External Beam Superficial Radiotherapy
        • 5.3.1.2. Internal Superficial Radiotherapy
      • 5.3.2. Global Superficial Radiation Therapy System by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Ambulatory Surgical Centers
        • 5.3.2.3. Cancer Centers
        • 5.3.2.4. Specialized Clinics
      • 5.3.3. Global Superficial Radiation Therapy System by: Disease Type (Volume)
        • 5.3.3.1. Dupuytren’s Contracture
        • 5.3.3.2. Heterotopic Ossification
        • 5.3.3.3. Ledderhose Disease
        • 5.3.3.4. Peyronie’s Disease
        • 5.3.3.5. Psoriasis
        • 5.3.3.6. Viral Warts
        • 5.3.3.7. Keloids
      • 5.3.4. Global Superficial Radiation Therapy System by: Treatment Type (Volume)
        • 5.3.4.1. Curative Treatment
        • 5.3.4.2. Palliative Treatment
      • 5.3.5. Global Superficial Radiation Therapy System Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Superficial Radiation Therapy System (Price)
      • 5.4.1. Global Superficial Radiation Therapy System by: Type (Price)
  • 6. Superficial Radiation Therapy System: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sensus Healthcare, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. OraSure Technologies Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Xstrahl Limited (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Nephros (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nordion Inc. (Canada)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. RaySearch Laboratories AB (Sweden)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Ion Beam Applications SA (Belgium)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Mevion Medical Systems Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Varian Medical Systems Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. IsoRay Medical Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Elekta AB (Sweden)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Mitsubishi Electric Corporation (Japan)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Superficial Radiation Therapy System Sale, by Type, Application, Disease Type, Treatment Type and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Superficial Radiation Therapy System (Value)
      • 7.2.1. Global Superficial Radiation Therapy System by: Type (Value)
        • 7.2.1.1. External Beam Superficial Radiotherapy
        • 7.2.1.2. Internal Superficial Radiotherapy
      • 7.2.2. Global Superficial Radiation Therapy System by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Ambulatory Surgical Centers
        • 7.2.2.3. Cancer Centers
        • 7.2.2.4. Specialized Clinics
      • 7.2.3. Global Superficial Radiation Therapy System by: Disease Type (Value)
        • 7.2.3.1. Dupuytren’s Contracture
        • 7.2.3.2. Heterotopic Ossification
        • 7.2.3.3. Ledderhose Disease
        • 7.2.3.4. Peyronie’s Disease
        • 7.2.3.5. Psoriasis
        • 7.2.3.6. Viral Warts
        • 7.2.3.7. Keloids
      • 7.2.4. Global Superficial Radiation Therapy System by: Treatment Type (Value)
        • 7.2.4.1. Curative Treatment
        • 7.2.4.2. Palliative Treatment
      • 7.2.5. Global Superficial Radiation Therapy System Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Superficial Radiation Therapy System (Volume)
      • 7.3.1. Global Superficial Radiation Therapy System by: Type (Volume)
        • 7.3.1.1. External Beam Superficial Radiotherapy
        • 7.3.1.2. Internal Superficial Radiotherapy
      • 7.3.2. Global Superficial Radiation Therapy System by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Ambulatory Surgical Centers
        • 7.3.2.3. Cancer Centers
        • 7.3.2.4. Specialized Clinics
      • 7.3.3. Global Superficial Radiation Therapy System by: Disease Type (Volume)
        • 7.3.3.1. Dupuytren’s Contracture
        • 7.3.3.2. Heterotopic Ossification
        • 7.3.3.3. Ledderhose Disease
        • 7.3.3.4. Peyronie’s Disease
        • 7.3.3.5. Psoriasis
        • 7.3.3.6. Viral Warts
        • 7.3.3.7. Keloids
      • 7.3.4. Global Superficial Radiation Therapy System by: Treatment Type (Volume)
        • 7.3.4.1. Curative Treatment
        • 7.3.4.2. Palliative Treatment
      • 7.3.5. Global Superficial Radiation Therapy System Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Superficial Radiation Therapy System (Price)
      • 7.4.1. Global Superficial Radiation Therapy System by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Superficial Radiation Therapy System: by Type(USD Million)
  • Table 2. Superficial Radiation Therapy System External Beam Superficial Radiotherapy , by Region USD Million (2015-2020)
  • Table 3. Superficial Radiation Therapy System Internal Superficial Radiotherapy , by Region USD Million (2015-2020)
  • Table 4. Superficial Radiation Therapy System: by Application(USD Million)
  • Table 5. Superficial Radiation Therapy System Hospitals , by Region USD Million (2015-2020)
  • Table 6. Superficial Radiation Therapy System Ambulatory Surgical Centers , by Region USD Million (2015-2020)
  • Table 7. Superficial Radiation Therapy System Cancer Centers , by Region USD Million (2015-2020)
  • Table 8. Superficial Radiation Therapy System Specialized Clinics , by Region USD Million (2015-2020)
  • Table 9. Superficial Radiation Therapy System: by Disease Type(USD Million)
  • Table 10. Superficial Radiation Therapy System Dupuytren’s Contracture , by Region USD Million (2015-2020)
  • Table 11. Superficial Radiation Therapy System Heterotopic Ossification , by Region USD Million (2015-2020)
  • Table 12. Superficial Radiation Therapy System Ledderhose Disease , by Region USD Million (2015-2020)
  • Table 13. Superficial Radiation Therapy System Peyronie’s Disease , by Region USD Million (2015-2020)
  • Table 14. Superficial Radiation Therapy System Psoriasis , by Region USD Million (2015-2020)
  • Table 15. Superficial Radiation Therapy System Viral Warts , by Region USD Million (2015-2020)
  • Table 16. Superficial Radiation Therapy System Keloids , by Region USD Million (2015-2020)
  • Table 17. Superficial Radiation Therapy System: by Treatment Type(USD Million)
  • Table 18. Superficial Radiation Therapy System Curative Treatment , by Region USD Million (2015-2020)
  • Table 19. Superficial Radiation Therapy System Palliative Treatment , by Region USD Million (2015-2020)
  • Table 20. South America Superficial Radiation Therapy System, by Country USD Million (2015-2020)
  • Table 21. South America Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 22. South America Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 23. South America Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 24. South America Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 25. Brazil Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 26. Brazil Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 27. Brazil Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 28. Brazil Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 29. Argentina Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 30. Argentina Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 31. Argentina Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 32. Argentina Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 33. Rest of South America Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 34. Rest of South America Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 35. Rest of South America Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 36. Rest of South America Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 37. Asia Pacific Superficial Radiation Therapy System, by Country USD Million (2015-2020)
  • Table 38. Asia Pacific Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 39. Asia Pacific Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 40. Asia Pacific Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 41. Asia Pacific Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 42. China Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 43. China Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 44. China Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 45. China Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 46. Japan Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 47. Japan Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 48. Japan Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 49. Japan Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 50. India Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 51. India Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 52. India Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 53. India Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 54. South Korea Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 55. South Korea Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 56. South Korea Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 57. South Korea Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 58. Taiwan Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 59. Taiwan Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 60. Taiwan Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 61. Taiwan Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 62. Australia Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 63. Australia Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 64. Australia Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 65. Australia Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 70. Europe Superficial Radiation Therapy System, by Country USD Million (2015-2020)
  • Table 71. Europe Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 72. Europe Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 73. Europe Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 74. Europe Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 75. Germany Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 76. Germany Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 77. Germany Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 78. Germany Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 79. France Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 80. France Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 81. France Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 82. France Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 83. Italy Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 84. Italy Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 85. Italy Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 86. Italy Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 87. United Kingdom Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 88. United Kingdom Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 89. United Kingdom Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 90. United Kingdom Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 91. Netherlands Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 92. Netherlands Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 93. Netherlands Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 94. Netherlands Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 95. Rest of Europe Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 96. Rest of Europe Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 97. Rest of Europe Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 98. Rest of Europe Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 99. MEA Superficial Radiation Therapy System, by Country USD Million (2015-2020)
  • Table 100. MEA Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 101. MEA Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 102. MEA Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 103. MEA Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 104. Middle East Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 105. Middle East Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 106. Middle East Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 107. Middle East Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 108. Africa Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 109. Africa Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 110. Africa Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 111. Africa Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 112. North America Superficial Radiation Therapy System, by Country USD Million (2015-2020)
  • Table 113. North America Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 114. North America Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 115. North America Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 116. North America Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 117. United States Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 118. United States Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 119. United States Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 120. United States Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 121. Canada Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 122. Canada Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 123. Canada Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 124. Canada Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 125. Mexico Superficial Radiation Therapy System, by Type USD Million (2015-2020)
  • Table 126. Mexico Superficial Radiation Therapy System, by Application USD Million (2015-2020)
  • Table 127. Mexico Superficial Radiation Therapy System, by Disease Type USD Million (2015-2020)
  • Table 128. Mexico Superficial Radiation Therapy System, by Treatment Type USD Million (2015-2020)
  • Table 129. Superficial Radiation Therapy System Sales: by Type(K Units)
  • Table 130. Superficial Radiation Therapy System Sales External Beam Superficial Radiotherapy , by Region K Units (2015-2020)
  • Table 131. Superficial Radiation Therapy System Sales Internal Superficial Radiotherapy , by Region K Units (2015-2020)
  • Table 132. Superficial Radiation Therapy System Sales: by Application(K Units)
  • Table 133. Superficial Radiation Therapy System Sales Hospitals , by Region K Units (2015-2020)
  • Table 134. Superficial Radiation Therapy System Sales Ambulatory Surgical Centers , by Region K Units (2015-2020)
  • Table 135. Superficial Radiation Therapy System Sales Cancer Centers , by Region K Units (2015-2020)
  • Table 136. Superficial Radiation Therapy System Sales Specialized Clinics , by Region K Units (2015-2020)
  • Table 137. Superficial Radiation Therapy System Sales: by Disease Type(K Units)
  • Table 138. Superficial Radiation Therapy System Sales Dupuytren’s Contracture , by Region K Units (2015-2020)
  • Table 139. Superficial Radiation Therapy System Sales Heterotopic Ossification , by Region K Units (2015-2020)
  • Table 140. Superficial Radiation Therapy System Sales Ledderhose Disease , by Region K Units (2015-2020)
  • Table 141. Superficial Radiation Therapy System Sales Peyronie’s Disease , by Region K Units (2015-2020)
  • Table 142. Superficial Radiation Therapy System Sales Psoriasis , by Region K Units (2015-2020)
  • Table 143. Superficial Radiation Therapy System Sales Viral Warts , by Region K Units (2015-2020)
  • Table 144. Superficial Radiation Therapy System Sales Keloids , by Region K Units (2015-2020)
  • Table 145. Superficial Radiation Therapy System Sales: by Treatment Type(K Units)
  • Table 146. Superficial Radiation Therapy System Sales Curative Treatment , by Region K Units (2015-2020)
  • Table 147. Superficial Radiation Therapy System Sales Palliative Treatment , by Region K Units (2015-2020)
  • Table 148. South America Superficial Radiation Therapy System Sales, by Country K Units (2015-2020)
  • Table 149. South America Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 150. South America Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 151. South America Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 152. South America Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 153. Brazil Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 154. Brazil Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 155. Brazil Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 156. Brazil Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 157. Argentina Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 158. Argentina Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 159. Argentina Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 160. Argentina Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 161. Rest of South America Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 162. Rest of South America Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 163. Rest of South America Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 164. Rest of South America Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 165. Asia Pacific Superficial Radiation Therapy System Sales, by Country K Units (2015-2020)
  • Table 166. Asia Pacific Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 167. Asia Pacific Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 168. Asia Pacific Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 169. Asia Pacific Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 170. China Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 171. China Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 172. China Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 173. China Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 174. Japan Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 175. Japan Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 176. Japan Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 177. Japan Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 178. India Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 179. India Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 180. India Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 181. India Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 182. South Korea Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 183. South Korea Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 184. South Korea Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 185. South Korea Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 186. Taiwan Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 187. Taiwan Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 188. Taiwan Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 189. Taiwan Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 190. Australia Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 191. Australia Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 192. Australia Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 193. Australia Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 194. Rest of Asia-Pacific Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 195. Rest of Asia-Pacific Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 196. Rest of Asia-Pacific Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 197. Rest of Asia-Pacific Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 198. Europe Superficial Radiation Therapy System Sales, by Country K Units (2015-2020)
  • Table 199. Europe Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 200. Europe Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 201. Europe Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 202. Europe Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 203. Germany Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 204. Germany Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 205. Germany Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 206. Germany Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 207. France Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 208. France Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 209. France Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 210. France Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 211. Italy Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 212. Italy Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 213. Italy Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 214. Italy Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 215. United Kingdom Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 216. United Kingdom Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 217. United Kingdom Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 218. United Kingdom Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 219. Netherlands Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 220. Netherlands Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 221. Netherlands Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 222. Netherlands Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 223. Rest of Europe Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 224. Rest of Europe Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 225. Rest of Europe Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 226. Rest of Europe Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 227. MEA Superficial Radiation Therapy System Sales, by Country K Units (2015-2020)
  • Table 228. MEA Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 229. MEA Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 230. MEA Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 231. MEA Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 232. Middle East Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 233. Middle East Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 234. Middle East Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 235. Middle East Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 236. Africa Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 237. Africa Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 238. Africa Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 239. Africa Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 240. North America Superficial Radiation Therapy System Sales, by Country K Units (2015-2020)
  • Table 241. North America Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 242. North America Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 243. North America Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 244. North America Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 245. United States Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 246. United States Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 247. United States Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 248. United States Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 249. Canada Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 250. Canada Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 251. Canada Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 252. Canada Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 253. Mexico Superficial Radiation Therapy System Sales, by Type K Units (2015-2020)
  • Table 254. Mexico Superficial Radiation Therapy System Sales, by Application K Units (2015-2020)
  • Table 255. Mexico Superficial Radiation Therapy System Sales, by Disease Type K Units (2015-2020)
  • Table 256. Mexico Superficial Radiation Therapy System Sales, by Treatment Type K Units (2015-2020)
  • Table 257. Superficial Radiation Therapy System: by Type(USD/Units)
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Superficial Radiation Therapy System: by Type(USD Million)
  • Table 271. Superficial Radiation Therapy System External Beam Superficial Radiotherapy , by Region USD Million (2021-2026)
  • Table 272. Superficial Radiation Therapy System Internal Superficial Radiotherapy , by Region USD Million (2021-2026)
  • Table 273. Superficial Radiation Therapy System: by Application(USD Million)
  • Table 274. Superficial Radiation Therapy System Hospitals , by Region USD Million (2021-2026)
  • Table 275. Superficial Radiation Therapy System Ambulatory Surgical Centers , by Region USD Million (2021-2026)
  • Table 276. Superficial Radiation Therapy System Cancer Centers , by Region USD Million (2021-2026)
  • Table 277. Superficial Radiation Therapy System Specialized Clinics , by Region USD Million (2021-2026)
  • Table 278. Superficial Radiation Therapy System: by Disease Type(USD Million)
  • Table 279. Superficial Radiation Therapy System Dupuytren’s Contracture , by Region USD Million (2021-2026)
  • Table 280. Superficial Radiation Therapy System Heterotopic Ossification , by Region USD Million (2021-2026)
  • Table 281. Superficial Radiation Therapy System Ledderhose Disease , by Region USD Million (2021-2026)
  • Table 282. Superficial Radiation Therapy System Peyronie’s Disease , by Region USD Million (2021-2026)
  • Table 283. Superficial Radiation Therapy System Psoriasis , by Region USD Million (2021-2026)
  • Table 284. Superficial Radiation Therapy System Viral Warts , by Region USD Million (2021-2026)
  • Table 285. Superficial Radiation Therapy System Keloids , by Region USD Million (2021-2026)
  • Table 286. Superficial Radiation Therapy System: by Treatment Type(USD Million)
  • Table 287. Superficial Radiation Therapy System Curative Treatment , by Region USD Million (2021-2026)
  • Table 288. Superficial Radiation Therapy System Palliative Treatment , by Region USD Million (2021-2026)
  • Table 289. South America Superficial Radiation Therapy System, by Country USD Million (2021-2026)
  • Table 290. South America Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 291. South America Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 292. South America Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 293. South America Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 294. Brazil Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 295. Brazil Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 296. Brazil Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 297. Brazil Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 298. Argentina Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 299. Argentina Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 300. Argentina Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 301. Argentina Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 302. Rest of South America Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 303. Rest of South America Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 304. Rest of South America Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 305. Rest of South America Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 306. Asia Pacific Superficial Radiation Therapy System, by Country USD Million (2021-2026)
  • Table 307. Asia Pacific Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 308. Asia Pacific Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 309. Asia Pacific Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 310. Asia Pacific Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 311. China Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 312. China Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 313. China Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 314. China Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 315. Japan Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 316. Japan Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 317. Japan Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 318. Japan Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 319. India Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 320. India Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 321. India Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 322. India Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 323. South Korea Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 324. South Korea Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 325. South Korea Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 326. South Korea Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 327. Taiwan Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 328. Taiwan Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 329. Taiwan Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 330. Taiwan Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 331. Australia Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 332. Australia Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 333. Australia Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 334. Australia Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 335. Rest of Asia-Pacific Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 336. Rest of Asia-Pacific Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 337. Rest of Asia-Pacific Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 338. Rest of Asia-Pacific Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 339. Europe Superficial Radiation Therapy System, by Country USD Million (2021-2026)
  • Table 340. Europe Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 341. Europe Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 342. Europe Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 343. Europe Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 344. Germany Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 345. Germany Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 346. Germany Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 347. Germany Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 348. France Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 349. France Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 350. France Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 351. France Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 352. Italy Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 353. Italy Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 354. Italy Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 355. Italy Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 356. United Kingdom Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 357. United Kingdom Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 358. United Kingdom Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 359. United Kingdom Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 360. Netherlands Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 361. Netherlands Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 362. Netherlands Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 363. Netherlands Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 364. Rest of Europe Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 365. Rest of Europe Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 366. Rest of Europe Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 367. Rest of Europe Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 368. MEA Superficial Radiation Therapy System, by Country USD Million (2021-2026)
  • Table 369. MEA Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 370. MEA Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 371. MEA Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 372. MEA Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 373. Middle East Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 374. Middle East Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 375. Middle East Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 376. Middle East Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 377. Africa Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 378. Africa Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 379. Africa Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 380. Africa Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 381. North America Superficial Radiation Therapy System, by Country USD Million (2021-2026)
  • Table 382. North America Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 383. North America Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 384. North America Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 385. North America Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 386. United States Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 387. United States Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 388. United States Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 389. United States Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 390. Canada Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 391. Canada Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 392. Canada Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 393. Canada Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 394. Mexico Superficial Radiation Therapy System, by Type USD Million (2021-2026)
  • Table 395. Mexico Superficial Radiation Therapy System, by Application USD Million (2021-2026)
  • Table 396. Mexico Superficial Radiation Therapy System, by Disease Type USD Million (2021-2026)
  • Table 397. Mexico Superficial Radiation Therapy System, by Treatment Type USD Million (2021-2026)
  • Table 398. Superficial Radiation Therapy System Sales: by Type(K Units)
  • Table 399. Superficial Radiation Therapy System Sales External Beam Superficial Radiotherapy , by Region K Units (2021-2026)
  • Table 400. Superficial Radiation Therapy System Sales Internal Superficial Radiotherapy , by Region K Units (2021-2026)
  • Table 401. Superficial Radiation Therapy System Sales: by Application(K Units)
  • Table 402. Superficial Radiation Therapy System Sales Hospitals , by Region K Units (2021-2026)
  • Table 403. Superficial Radiation Therapy System Sales Ambulatory Surgical Centers , by Region K Units (2021-2026)
  • Table 404. Superficial Radiation Therapy System Sales Cancer Centers , by Region K Units (2021-2026)
  • Table 405. Superficial Radiation Therapy System Sales Specialized Clinics , by Region K Units (2021-2026)
  • Table 406. Superficial Radiation Therapy System Sales: by Disease Type(K Units)
  • Table 407. Superficial Radiation Therapy System Sales Dupuytren’s Contracture , by Region K Units (2021-2026)
  • Table 408. Superficial Radiation Therapy System Sales Heterotopic Ossification , by Region K Units (2021-2026)
  • Table 409. Superficial Radiation Therapy System Sales Ledderhose Disease , by Region K Units (2021-2026)
  • Table 410. Superficial Radiation Therapy System Sales Peyronie’s Disease , by Region K Units (2021-2026)
  • Table 411. Superficial Radiation Therapy System Sales Psoriasis , by Region K Units (2021-2026)
  • Table 412. Superficial Radiation Therapy System Sales Viral Warts , by Region K Units (2021-2026)
  • Table 413. Superficial Radiation Therapy System Sales Keloids , by Region K Units (2021-2026)
  • Table 414. Superficial Radiation Therapy System Sales: by Treatment Type(K Units)
  • Table 415. Superficial Radiation Therapy System Sales Curative Treatment , by Region K Units (2021-2026)
  • Table 416. Superficial Radiation Therapy System Sales Palliative Treatment , by Region K Units (2021-2026)
  • Table 417. South America Superficial Radiation Therapy System Sales, by Country K Units (2021-2026)
  • Table 418. South America Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 419. South America Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 420. South America Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 421. South America Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 422. Brazil Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 423. Brazil Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 424. Brazil Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 425. Brazil Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 426. Argentina Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 427. Argentina Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 428. Argentina Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 429. Argentina Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 430. Rest of South America Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 431. Rest of South America Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 432. Rest of South America Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 433. Rest of South America Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 434. Asia Pacific Superficial Radiation Therapy System Sales, by Country K Units (2021-2026)
  • Table 435. Asia Pacific Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 436. Asia Pacific Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 437. Asia Pacific Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 438. Asia Pacific Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 439. China Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 440. China Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 441. China Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 442. China Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 443. Japan Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 444. Japan Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 445. Japan Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 446. Japan Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 447. India Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 448. India Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 449. India Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 450. India Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 451. South Korea Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 452. South Korea Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 453. South Korea Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 454. South Korea Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 455. Taiwan Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 456. Taiwan Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 457. Taiwan Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 458. Taiwan Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 459. Australia Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 460. Australia Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 461. Australia Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 462. Australia Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 463. Rest of Asia-Pacific Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 464. Rest of Asia-Pacific Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 465. Rest of Asia-Pacific Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 466. Rest of Asia-Pacific Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 467. Europe Superficial Radiation Therapy System Sales, by Country K Units (2021-2026)
  • Table 468. Europe Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 469. Europe Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 470. Europe Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 471. Europe Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 472. Germany Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 473. Germany Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 474. Germany Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 475. Germany Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 476. France Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 477. France Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 478. France Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 479. France Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 480. Italy Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 481. Italy Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 482. Italy Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 483. Italy Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 484. United Kingdom Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 485. United Kingdom Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 486. United Kingdom Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 487. United Kingdom Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 488. Netherlands Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 489. Netherlands Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 490. Netherlands Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 491. Netherlands Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 492. Rest of Europe Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 493. Rest of Europe Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 494. Rest of Europe Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 495. Rest of Europe Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 496. MEA Superficial Radiation Therapy System Sales, by Country K Units (2021-2026)
  • Table 497. MEA Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 498. MEA Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 499. MEA Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 500. MEA Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 501. Middle East Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 502. Middle East Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 503. Middle East Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 504. Middle East Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 505. Africa Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 506. Africa Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 507. Africa Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 508. Africa Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 509. North America Superficial Radiation Therapy System Sales, by Country K Units (2021-2026)
  • Table 510. North America Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 511. North America Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 512. North America Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 513. North America Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 514. United States Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 515. United States Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 516. United States Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 517. United States Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 518. Canada Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 519. Canada Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 520. Canada Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 521. Canada Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 522. Mexico Superficial Radiation Therapy System Sales, by Type K Units (2021-2026)
  • Table 523. Mexico Superficial Radiation Therapy System Sales, by Application K Units (2021-2026)
  • Table 524. Mexico Superficial Radiation Therapy System Sales, by Disease Type K Units (2021-2026)
  • Table 525. Mexico Superficial Radiation Therapy System Sales, by Treatment Type K Units (2021-2026)
  • Table 526. Superficial Radiation Therapy System: by Type(USD/Units)
  • Table 527. Research Programs/Design for This Report
  • Table 528. Key Data Information from Secondary Sources
  • Table 529. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Superficial Radiation Therapy System: by Type USD Million (2015-2020)
  • Figure 5. Global Superficial Radiation Therapy System: by Application USD Million (2015-2020)
  • Figure 6. Global Superficial Radiation Therapy System: by Disease Type USD Million (2015-2020)
  • Figure 7. Global Superficial Radiation Therapy System: by Treatment Type USD Million (2015-2020)
  • Figure 8. South America Superficial Radiation Therapy System Share (%), by Country
  • Figure 9. Asia Pacific Superficial Radiation Therapy System Share (%), by Country
  • Figure 10. Europe Superficial Radiation Therapy System Share (%), by Country
  • Figure 11. MEA Superficial Radiation Therapy System Share (%), by Country
  • Figure 12. North America Superficial Radiation Therapy System Share (%), by Country
  • Figure 13. Global Superficial Radiation Therapy System: by Type K Units (2015-2020)
  • Figure 14. Global Superficial Radiation Therapy System: by Application K Units (2015-2020)
  • Figure 15. Global Superficial Radiation Therapy System: by Disease Type K Units (2015-2020)
  • Figure 16. Global Superficial Radiation Therapy System: by Treatment Type K Units (2015-2020)
  • Figure 17. South America Superficial Radiation Therapy System Share (%), by Country
  • Figure 18. Asia Pacific Superficial Radiation Therapy System Share (%), by Country
  • Figure 19. Europe Superficial Radiation Therapy System Share (%), by Country
  • Figure 20. MEA Superficial Radiation Therapy System Share (%), by Country
  • Figure 21. North America Superficial Radiation Therapy System Share (%), by Country
  • Figure 22. Global Superficial Radiation Therapy System: by Type USD/Units (2015-2020)
  • Figure 23. Global Superficial Radiation Therapy System share by Players 2020 (%)
  • Figure 24. Global Superficial Radiation Therapy System share by Players (Top 3) 2020(%)
  • Figure 25. Global Superficial Radiation Therapy System share by Players (Top 5) 2020(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Sensus Healthcare, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Sensus Healthcare, Inc. (United States) Revenue: by Geography 2020
  • Figure 29. OraSure Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. OraSure Technologies Inc. (United States) Revenue: by Geography 2020
  • Figure 31. Xstrahl Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Xstrahl Limited (United Kingdom) Revenue: by Geography 2020
  • Figure 33. Nephros (United States) Revenue, Net Income and Gross profit
  • Figure 34. Nephros (United States) Revenue: by Geography 2020
  • Figure 35. Nordion Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 36. Nordion Inc. (Canada) Revenue: by Geography 2020
  • Figure 37. RaySearch Laboratories AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 38. RaySearch Laboratories AB (Sweden) Revenue: by Geography 2020
  • Figure 39. Ion Beam Applications SA (Belgium) Revenue, Net Income and Gross profit
  • Figure 40. Ion Beam Applications SA (Belgium) Revenue: by Geography 2020
  • Figure 41. Mevion Medical Systems Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Mevion Medical Systems Inc. (United States) Revenue: by Geography 2020
  • Figure 43. Varian Medical Systems Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Varian Medical Systems Inc. (United States) Revenue: by Geography 2020
  • Figure 45. IsoRay Medical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 46. IsoRay Medical Inc. (United States) Revenue: by Geography 2020
  • Figure 47. Elekta AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 48. Elekta AB (Sweden) Revenue: by Geography 2020
  • Figure 49. Mitsubishi Electric Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 50. Mitsubishi Electric Corporation (Japan) Revenue: by Geography 2020
  • Figure 51. Global Superficial Radiation Therapy System: by Type USD Million (2021-2026)
  • Figure 52. Global Superficial Radiation Therapy System: by Application USD Million (2021-2026)
  • Figure 53. Global Superficial Radiation Therapy System: by Disease Type USD Million (2021-2026)
  • Figure 54. Global Superficial Radiation Therapy System: by Treatment Type USD Million (2021-2026)
  • Figure 55. South America Superficial Radiation Therapy System Share (%), by Country
  • Figure 56. Asia Pacific Superficial Radiation Therapy System Share (%), by Country
  • Figure 57. Europe Superficial Radiation Therapy System Share (%), by Country
  • Figure 58. MEA Superficial Radiation Therapy System Share (%), by Country
  • Figure 59. North America Superficial Radiation Therapy System Share (%), by Country
  • Figure 60. Global Superficial Radiation Therapy System: by Type K Units (2021-2026)
  • Figure 61. Global Superficial Radiation Therapy System: by Application K Units (2021-2026)
  • Figure 62. Global Superficial Radiation Therapy System: by Disease Type K Units (2021-2026)
  • Figure 63. Global Superficial Radiation Therapy System: by Treatment Type K Units (2021-2026)
  • Figure 64. South America Superficial Radiation Therapy System Share (%), by Country
  • Figure 65. Asia Pacific Superficial Radiation Therapy System Share (%), by Country
  • Figure 66. Europe Superficial Radiation Therapy System Share (%), by Country
  • Figure 67. MEA Superficial Radiation Therapy System Share (%), by Country
  • Figure 68. North America Superficial Radiation Therapy System Share (%), by Country
  • Figure 69. Global Superficial Radiation Therapy System: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Sensus Healthcare, Inc. (United States)
  • OraSure Technologies Inc. (United States)
  • Xstrahl Limited (United Kingdom)
  • Nephros (United States)
  • Nordion Inc. (Canada)
  • RaySearch Laboratories AB (Sweden)
  • Ion Beam Applications SA (Belgium)
  • Mevion Medical Systems Inc. (United States)
  • Varian Medical Systems Inc. (United States)
  • IsoRay Medical Inc. (United States)
  • Elekta AB (Sweden)
  • Mitsubishi Electric Corporation (Japan)
Select User Access Type

Key Highlights of Report


Oct 2021 211 Pages 57 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"The Rising Incidence of Various Types of Cancers " is seen as one of major growth factors of Superficial Radiation Therapy System Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
United States will lead Superficial Radiation Therapy System Market in coming years.

Know More About Global Superficial Radiation Therapy System Market Report?